Introducing electronic monitoring of disease activity in patients with chronic inflammatory demyelinating polyneuropathy (EMDA CIDP): trial protocol of a proof of concept study.
Lars MasanneckJan VothNiklas HuntemannMenekse ÖztürkChristina B SchroeterTobias RuckSven G MeuthMarc PawlitzkiPublished in: Neurological research and practice (2023)
The study protocol was registered at ClinicalTrials.gov. Identifier: NCT05723848. Initially, the protocol was submitted prospectively on January 10, 2023. The trial was publicly released after formal improvements on February 13, 2023, after first patients were included according to the original protocol.
Keyphrases
- study protocol
- randomized controlled trial
- disease activity
- rheumatoid arthritis
- systemic lupus erythematosus
- end stage renal disease
- clinical trial
- phase iii
- rheumatoid arthritis patients
- ejection fraction
- phase ii
- prognostic factors
- chronic kidney disease
- oxidative stress
- peritoneal dialysis
- juvenile idiopathic arthritis
- patient reported outcomes